A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector Mediated Gene Transfer of Human Factor VIII at a dose of 4E13 vg/kg inHemophilia A Patients with Residual FVIII Levels

Project: Research project

Project Details

Description

A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno- Associated Virus Vector Mediated Gene Transfer of Human Factor VIII at a dose of 4E13 vg/kg in Hemophilia A Patients with Residual FVIII Levels
StatusFinished
Effective start/end date7/15/18 → 7/15/23

Funding

  • BIOMARIN PHARMACEUTICAL, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint